Lumos Pharma Inc expected to post a loss of $1.24 a share - Earnings Preview

Lumos Pharma

30/07/2024 23:49

* Lumos Pharma Inc  LUMO.OQ   LUMO.O  is expected to show a
fall
in quarterly revenue when it reports  results on August 1 for
the period ending June 30 2024
    * The Austin Texas-based  company is expected to report a
36.7% decrease in revenue to $333.33 thousand from $527 thousand
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Lumos Pharma Inc is for
a loss
of $1.24 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $23.00​, above​ its last closing price of $1.80. ​​​

This summary was machine generated July 30 at 22:49 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)